Nuvalent, Inc. ($NUVL)
Filing Information
| Accession Number | 0001193125-26-006576 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
40,160
Total Value
$501,752.89
P&L
+inf% (+$3,316,950.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 513 | $96.06 | $49,278.78 | 70,535 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 660 | $96.85 | $63,921.00 | 69,875 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 1,137 | $97.96 | $111,380.52 | 68,738 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 186 | $98.52 | $18,324.72 | 68,552 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 6, 2026 | Sale | 1,106 | $96.75 | $107,005.50 | 67,446 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 6, 2026 | Sale | 1,369 | $97.33 | $133,244.77 | 66,077 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 6, 2026 | Sale | 189 | $98.40 | $18,597.60 | 65,888 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 7, 2026 | Grant/Award | 17,500 | $0.00 | $0.00 | 83,388 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Grant/Award | 17,500 | $0.00 | $0.00 | 17,500 | Direct | โ | View Details |